1.
Emerg Infect Dis
; 24(3): 584-587, 2018 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29460760
RESUMO
In 2015, Clostridium difficile testing rates among 30 US community, multispecialty, and cancer hospitals were 14.0, 16.3, and 33.9/1,000 patient-days, respectively. Pooled hospital onset rates were 0.56, 0.84, and 1.57/1,000 patient-days, respectively. Higher testing rates may artificially inflate reported rates of C. difficile infection. C. difficile surveillance should consider testing frequency.